Indications & Usage
Directions: FOR ORAL USE.
Bambusa Stannum
FDA Label NDC 48951-2018
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Uriel Pharmacy Inc. for the product Bambusa Stannum (NDC 48951-2018). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding indications & usage, dosage & administration, otc - active ingredient, inactive ingredient, otc - purpose, otc - keep out of reach of children, warnings, otc - questions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Dosage & Administration
Take the contents of one ampule under the tongue and hold for 30 seconds, then swallow.
Otc - Active Ingredient
Active Ingredients: Bambusa (Bamboo) 6X, Betonica (Wood betony) 6X, Disci interv. (Bovine intervertebral discs of the cervical, thoracic and lumbar spine) 6X, Rosmarinus (Rosemary) 6X, Formica (Red wood ant) 7X, Stannum (Metallic tin) 7X, Jasper (Semiprecious stone) 12X, Equisetum (Common horsetail) 15X
Inactive Ingredient
Inactive Ingredients: Water, Salt, Lactose
Otc - Purpose
Use: Temporary relief of headache.
Otc - Keep Out Of Reach Of Children
KEEP OUT OF REACH OF CHILDREN.
Warnings
Warnings: Do not use if allergic to any ingredient. Contains traces of lactose. Consult a doctor before use for serious conditions or if conditions worsen or persist. If pregnant or nursing, consult a doctor before use.
Otc - Questions
Questions? Call 866.642.2858
Made by Uriel, East Troy, WI 53120
www.urielpharmacy.com
* Please review the disclaimer below.
